SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : IFMX - Investment Discussion -- Ignore unavailable to you. Want to Upgrade?


To: Hardly B. Solipsist who wrote (12168)10/22/1998 9:46:00 PM
From: Sycamore  Read Replies (2) | Respond to of 14631
 
<<To get to $20 won't IFMX have to make over $1/share of the right>>

Hardly,

I don't know about $20 but as far as I know there were various buy recommendations made recently with a 12 month target price of $12 or more on the stock. Interestingly enough that occurred with much lower expectations of earning and growth revenues. See report below. Obviously the company is now delivering on those--improved revenues that resulted with 17 cents of earnings already for just the last 3-quarters alone. If the company earns 10-12 cents this period then you compute (17 + 10-12 cents).

Anyway, below is a snapshot of the recommendation from one of the analysts who follows the stock. Unfortunately, can't obtain reports of other firms "buy" recommendations on IFMX with target prices.

sycamore


CIBC Oppenheimer Corp. issued Company Report

On May 21, 1998 CIBC Oppenheimer Corp. analyst Melissa Eisenstat issued a 5 page Company Report on INFORMIX CORP. Report highlights: " The 1998 EPS estimate was reduced from $0.15 to $0.14. A BUY rating was maintained with a price target of $12. The company reported a 1998 first quarter loss of $0.01 per share versus a loss of $0.71 per share for the same quarter in the previous year. "

Melissa Eisenstat is ranked 15 out of 26 when predicting changes in stock prices for Informix Corporation.

Melissa Eisenstat has not made enough EPS forecasts to be meaningfully ranked relative to 25 other analysts following the same company.